These results suggested that NK1R was not a specific marker of NEPC, but it may serve as a potential marker indicating the progression from luminal-type adenocarcinoma toward NEPC, especially under the circumstance of AR-targeted therapies. This evidence concerns the gene AR and adenocarcinoma.